Ta strona używa pliki cookies, w celu polepszenia użyteczności i funkcjonalności oraz w celach statystycznych. Dowiedz się więcej w Polityce prywatności.
Korzystając ze strony wyrażasz zgodę na używanie plików cookies, zgodnie z aktualnymi ustawieniami przeglądarki.
Akceptuję wykorzystanie plików cookies
Family Medicine & Primary Care Review
eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
1/2025
vol. 27
 
Share:
Send email
Share:
Review paper

Recommendations of Polish experts for 2024 on the co-administration of vaccines in adults for the prevention of respiratory infections

Adam Antczak
1, 2
,
Mikołaj Konstanty
3
,
Ernest Kuchar
4
,
Agnieszka Mastalerz-Migas
5, 6
,
Aneta Nitsch-Osuch
7
,
Miłosz Parczewski
8
,
Jacek Wysocki
9

  1. Scientific Council of the National Program for the Control of Infectious Diseases, Poland
  2. Department of General and Oncological Pulmonology, Medical University of Lodz, Lodz, Poland
  3. Supreme Pharmacy Chamber, Warsaw, Poland
  4. Department of Pediatrics with and Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland
  5. Polish Society of Family Medicine
  6. Department of Family Medicine, Wroclaw Medical University, Wroclaw, Poland
  7. Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland
  8. Department of Infectious, Tropical Diseases and Acquired Immunodeficiencies, Pomeranian Medical University in Szczecin, Szczecin, Poland
  9. Department of Health Prevention, Faculty of Health Sciences, Poznan Medical University, Poz-nan, Poland
Family Medicine & Primary Care Review 2025; 27(1): 123–128
DOI: https://doi.org/10.5114/fmpcr.2025.146977
Online publish date: 2025/03/26
Article file
- 19 FM&PCR 1 25 - CME - Antczak - 1721 - Recommendations.pdf  [0.24 MB]
Get citation
 
PlumX metrics:
 
1. WHO SAGE coadministration of seasonal inactivated influenza and COVID-19 vaccines [cited 31.08.2024]. Available from URL: https://www.paho.org/en/documents/sage-coadministration-seasonal-inactivated-influenza-and-covid-19-vaccines.
2. WHO SAGE Immunization, Vaccines, and Biologicals [cited 31.08.2024]. Available from URL: https://www.who.int/teams/immunization-vaccines-and-biologicals/essential-programme-on-immunization.
3. ECDC – European Centre for Disease Prevention and Control Interim public health considerations for the provision of additional COVID-19 vaccine doses Technical Report [cited 31.08.2024]. Available from URL: www.ecdc.europa.eu/sites/default/files/documents/covid-19-overview-of-the-implementation-of-vaccination-strategies-and-deployment-plans-11-november-2021.pdf.
4. ACIP – Advisory Committee on Immunization Practices: General Best Practices for Immunization Timing and Spacing of Immunobiologics [cited 31.08.2024]. Available from URL: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html.
5. NHS – National Health Service: Immunisation against infectious disease Green Book Chapter 27a: Respiratory syncytial virus [cited 31.08.2024]. Available from URL: https://www.gov.uk/government/publications/rotavirus-the-green-book-chapter-27b.
6. NHS – National Health Service: Immunisation against infectious disease Green Book Chapter 11 UK Immunisation Schedule [cited 31.08.2024]. Available from URL: https://www.gov.uk/government/publications/immunisation-schedule-the-green-book-chapter-11.
7. Canada Public Health service Timing of vaccine administration: Canadian Immunization Guide [cited 31.08.2024]. Available from URL: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-1-key-immunization-information/page-10-timing-vaccine-administration.html.
8. Respiratory syncytial virus (RSV) vaccines: Canadian Immunization Guide [cited 31.08.2024]. Available from URL: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/respiratory-syncytial-virus.html.
9. National Centre for Immunisation Research and Surveillance (NCIRS) Australia, Coadministration of vaccines for adults: a guide for immunisation providers [cited 31.08.2024]. Available from URL: www.ncirs.org.au/sites/default/files/2022-08/Co-administra-tion%2520of%2520vaccine%2520guide%2520for%2520Adullts_3%2520Aug%25202022_final.pdf&ved=2ahUKEwj-3c7p-diIAxVxcfEDHdZrGuwQFnoECBgQAQ&usg=AOvVaw0ji45NEEmYAeXTu_LmUs_k.
10. Statement of the Standing Commission on Vaccination (STIKO) at the Robert Koch Institute Decision on the implementation of the COVID-19 vaccination into the general recommendations of the STIKO 2023 [cited 31.08.2024]. Available from URL: https://www.rki.de/EN/Content/infections/Vaccination/recommandations/implementation_covid-19_vaccination.pdf?__blob=publicationFile.
11. HAS – Haute Autorité de Santé Stratégie de vaccination contre la Covid-19: actualisation des recommandations relatives à l’administration concomitante des vaccins contre la Covid-19 et contre la grippe saisonnière [cited 31.08.2024]. Available from URL: https://www.has-sante.fr/jcms/p_3451801/fr/strategie-de-vaccination-contre-la-covid-19-actualisation-des-recommandations-relatives-a-l-administration-concomitante-des-vaccins-contre-la-covid-19-et-contre-la-grippe-saisonniere (in French).
12. FOPH – Federal Office of Public Health: National Vaccination Strategy (NVS) [cited 31.08.2024]. Available from URL: https://www.bag.admin.ch/bag/en/home/strategie-und-politik/nationale-gesundheitsstrategien/nationale-strategie-impfungen-nsi.html.
13. MHLW – Ministry of Health, Labour and Welfare [cited 31.08.2024]. Available from URL: https://www.mhlw.go.jp/english/.
14. Bonanni P, Steffen R, Schelling J, et al. Vaccine coadministration in adults: An effective way to im-prove vaccination coverage. Hum Vaccin Immunother 2023;19(1): 2195786, doi: 10.1080/21645515.2023.2195786.
15. Raport szczepień przeciwko COVID-19 [cited 31.08.2024]. Available from URL: https://www.gov.pl/web/szczepimysie/raport-szczepien-przeciwko-covid-19 (in Polish).
16. Lewin B, Qian L, Huang R, et al. Travelers and travel vaccines at six health care systems in the Vac-cine Safety Datalink. Vaccine 2022; 40(41): 5904–5911, doi: 10.1016/j.vaccine.2022.08.023.
17. King GE, Hadler SC. Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. Pediatr Infect Dis J 1994; 13(5): 394–407.
18. Kobayashi M, Bennett NM, Gierke R, et al. Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2015 Sep; 64(34): 944–997, doi: 10.15585/mmwr.mm6434a4.
19. Buchwald UK, Andrews CP, Ervin J, et al. Sequential administration of Prevnar 13™ and PNEU-MOVAX™ 23 in healthy participants 50 years of age and older. Hum Vaccin Immunother 2021; 17(8): 2678–2690, doi: 10.1080/21645515.2021.1888621.
20. Standing orders for Administering Pneumococcal Vaccines to Adults [cited 31.08.2024]. Available from URL: https://www.immunize.org/wp-content/uploads/catg.d/p3075.pdf.
21. Australian Immunisation Handbook. Pneumococcal disease [cited 31.08.2024]. Available from URL: https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/pneumococcal-disease.
22. Vernacchio L, Neufeld EJ, MacDonald K, et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr 1998; 133: 275–278.
23. Vernacchio L, Romero-Steiner S, Martinez JE, et al. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vac-cines in children and young adults with sickle cell disease. J Infect Dis 2000; 181: 1162–1166.
24. Australian Immunisation Handbook. Cholera [cited 31.08.2024]. Available from URL: https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/cholera
25. Collins JP, Ryan ET, Wong KK, et al. Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022. MMWR Recomm Rep 2022; 71(2): 1–8, doi: 10.15585/mmwr.rr7102a1.
26. CDC. Recommendation of the Advisory Committee on Immunization Practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MenACWY-D) among children aged 9 through 23 months at increased risk for invasive meningococcal disease. MMWR Morb Mortal Wkly Rep 2011; 60(40): 1391–1392.
27. Achterbergh RCA, McGovern I, Haag M. Coadministration of Influenza and COVID-19 Vaccines: Policy Review and Vaccination Coverage Trends in the European Union, UK, US, and Canada be-tween 2019 and 2023. Vaccines (Basel) 2024; 12(2): 216.
28. Vaccine Administration General Best Practices for Immunization Infection Control and Sterile Technique [cited 31.08.2024]. Available from URL: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html.
Copyright: © 2025 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.